Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits

Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits  Reuters

Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.